Manufacturing battery cells in Polatlı is not a light claim on paper; it is a heavy claim in the field. Lithium iron phosphate cells, battery packs, energy storage systems, mobile substations, e-houses, mining, satellites, robots: Kontrolmatik’s 2026 Q1 activity report opens like a catalogue of the energy transition. But the 2026 first-quarter ledger places a rougher object between the pages of that catalogue: the cable of paid-in capital.
On 31 March 2026, the company carried 13.06 billion TL of net financial debt. Immediately after the quarter ended, management applied for a 2.6 billion TL cash capital increase to raise paid-in capital from 1.3 billion TL to 3.9 billion TL. This is not the ordinary refuelling of a growth company; it is the recharging of an industrial option whose balance sheet is being squeezed by short maturity and interest.
The question is no longer whether KONTR can make batteries. The question is whether this battery can produce cash without consuming shareholder capital.
The Debt Inside The Battery
The best part of the 2026 Q1 activity report is this: most of the businesses the company describes are not floating in the air. For Pomega, it describes an LFP battery cell and energy storage facility of roughly 100 thousand square meters in Polatlı; the report says the plant was commissioned in 2023 with 500 MWh, reached 3 GWh of annual capacity as of 2026, and targets 6 GWh in the near term. 4 MWh container systems, a 100 Ah cell line, POD products, field tests, certifications, and the implementation plan for the Enerjisa/Çimsa site all appear in concrete form.
So reading KONTR as an empty story would be lazy. The group owns real assets across power generation, transmission, distribution, storage, industrial automation, mobile substations, mining, software, and satellites. The Plan-S stake is carried in the financial statements at a fair value of 1.44 billion TL. The 2026 Q1 activity report also notes that Pomega previously received outside investment at a company valuation of 210 million US dollars.
But a real asset does not automatically mean a good stock. Especially when expensive time stands in front of those assets.
In 2026Q1, net revenue was 2.747 billion TL. Of this, 1.664 billion TL came from domestic sales and 1.084 billion TL from international sales. Gross profit was 575 million TL; the gross margin rose from 18.8 percent in the same period last year to 20.9 percent. At first glance, not bad. The hard part of the ledger begins after gross profit: after general administrative expenses, marketing, R&D, and other operating items, operating profit is only 70 million TL. EBITDA is 264 million TL; the EBITDA margin has fallen from 12.2 percent to 9.6 percent.
That thin operating cushion looks small next to the debt. The ratio table in the 2026 Q1 activity report shows net debt/EBITDA at 7.6x in 2025Q1 and 12.4x in 2026Q1. EBITDA/finance expense has fallen from 0.5x to 0.4x. The company is building factories on one side, while on the other side operating profit is not enough for the interest ledger.
The Inflation Shadow Over Profit
KONTR’s quarterly profit does not treat the reader kindly. The income statement shows 291 million TL of pre-tax profit. But inside that figure sits an 858 million TL net monetary position gain. In the same quarter, finance expenses were 633 million TL; operating profit was 70 million TL.
The tax line also turns the profit around. Of the 300 million TL tax expense, 299 million TL is deferred tax. The result is an 8 million TL loss for the period from continuing operations, while the parent-company share is 24 million TL profit. For a group carrying 2.75 billion TL of revenue and 13.06 billion TL of net debt, 24 million TL of parent-company profit cannot be the main pillar of the investment thesis.
Cash flow looks better: there is a 3.846 billion TL cash inflow from operating activities. That matters; cash should not be dismissed in a leveraged company. But the source is not clean profit conversion. In the cash-flow statement, deferred income rises by 1.952 billion TL and trade receivables fall by 1.384 billion TL, while interest paid is 1.032 billion TL and financing cash flow is -3.579 billion TL. This shows the company can breathe; it does not show that it can run a long race.
| Item | 2026Q1 | Read-through |
|---|---|---|
| Operating cash flow | TRY 3,846m | Strong headline |
| Increase in deferred revenue | TRY 1,952m | Advance/timing support |
| Decrease in trade receivables | TRY 1,384m | Collection support |
| Interest paid | TRY -1,032m | Heavy interest ledger |
| Financing cash flow | TRY -3,579m | Debt and interest outflow |
The Charge From The Shareholder
The company’s short-term liabilities are 21.31 billion TL, while current assets are 20.19 billion TL. The current ratio is 0.95. Short-term financial debt is 8.31 billion TL; cash on hand is 579 million TL. Put differently, short-term financial debt is roughly 14 times cash.
This tension is visible during the period as well. Paid-in capital, which was 650 million TL at the end of 2025, rose to 1.3 billion TL through a 100 percent rights issue. After the quarter, management this time asked for another 2.6 billion TL in cash through a 200 percent rights issue. If this second transaction is completed, the company’s capital will rise to 3.9 billion TL. Against a current market value of 10.39 billion TL, the requested new cash is roughly a quarter of the market value.
This is not a moral accusation; it is a financial fact. Growing industrial companies need capital. But at KONTR, the capital need now stands not around the growth option, but at the centre of the stock itself. The shareholder is partnering not only in the company’s products, but also in the company’s financing calendar.
The related-party table also deserves attention. The financial report shows 5.132 billion TL of other long-term payables to related parties; inside that are items for Sami Aslanhan, Ömer Ünsalan, and Kmt Teknolojik ve Finansal Yatırımlar. These debts are not a short-term panic item, but they remind the reader that the capital structure is intertwined with family/related-party financing. Every share in the company carries one voting right and there are no privileges; even so, the investor should know that economic control cannot be read only through the free float.
The currency side is exposed as well. On 31 March 2026, net foreign-currency liabilities were 4.781 billion TL; the financial report shows no off-balance-sheet hedge position. If the TL weakened by 10 percent at the same time against the USD, euro, and other currencies, pre-tax profit would be about 478 million TL lower. That figure is almost twenty times Q1 parent-company profit.
The Miracle The Price Requires
In the market data for 18 May 2026, KONTR’s price is 7.99 TL and its market value is 10.39 billion TL. Adding 13.06 billion TL of net financial debt to that gives an approximate enterprise value of 23.44 billion TL. Q1 EBITDA was 264 million TL; annualized roughly, that is 1.06 billion TL. The current enterprise value is 22.2 times that.
This is not a cheap multiple. This is the price of “today’s earning power does not matter; tomorrow’s options will open.”
| Bridge | Value | Source/read-through |
|---|---|---|
| Market value | TRY 10.39bn | Market data as of 18 May 2026 |
| Net financial debt | TRY 13.06bn | 2026Q1 financial report capital risk management note |
| Approximate enterprise value | TRY 23.44bn | Market value plus net financial debt |
| Q1 EBITDA | TRY 264m | 2026Q1 activity report performance summary |
| Annualized EV/EBITDA | 22.2x | The price assumes recovery, not current earnings power |
| Market value / parent equity | 1.6x | TRY 10.39bn / TRY 6.52bn |
The second valuation bridge must be more company-specific. Because inside KONTR there are different risk/duration profiles such as Pomega, Progresiva, Plan-S, Emek, mining, and robotics. The source surface does not give current market values for private subsidiaries; so instead of importing values, it is more honest to run a residual value test.
Plan-S is carried in the financial statements at 1.44 billion TL. If we subtract this from the market value and add net debt, the approximate enterprise value left for the operations and options outside Plan-S is still around 22.0 billion TL. Against annualized Q1 EBITDA, that is roughly 20.8x. In other words, Plan-S alone does not save the “cheapness” story.
If the rights issue is completed and the full 2.6 billion TL goes to debt/cash repair, net debt falls to 10.46 billion TL. That would be good news. But on the same rough annualized EBITDA, post-rights EV/EBITDA would still remain around 19.7x. To fall to a more reasonable industrial multiple like 10x, annual EBITDA would need to rise to roughly 2.08 billion TL; that is about twice the annualized Q1 level.
| Test | Calculation | Result | Read-through |
|---|---|---|---|
| Enterprise value excluding Plan-S | TRY 10.39bn market value - TRY 1.44bn Plan-S + TRY 13.06bn net debt | TRY 22.00bn | Plan-S alone does not rescue the cheapness argument. |
| Post-rights net debt check | TRY 13.06bn net debt - TRY 2.60bn rights cash | TRY 10.46bn | If fully collected and used for balance-sheet repair, leverage eases but remains high. |
| Post-rights EV/EBITDA | (TRY 10.39bn market value + TRY 10.46bn net debt) / TRY 1.06bn annualized EBITDA | 19.7x | The valuation still requires a sharp EBITDA recovery. |
| EBITDA needed for 10x EV/EBITDA | TRY 20.84bn post-rights EV / 10x | TRY 2.08bn annual EBITDA | About 2.0x current annualized Q1 EBITDA. |
| Pomega external mark | USD 210m company valuation x 88.1% stake | USD 185m look-through reference | Real option evidence, but not enough by itself to erase TRY leverage pressure. |
So the valuation judgment is this: KONTR is not “trash,” but at the current price it is not cheap on today’s financials either. The price is buying Pomega’s move from the language of capacity and certification into the language of cash-producing factory, Progresiva opening its licence/financing path without tiring capital again, exports bringing durable margin, and the debt multiple falling quickly.
Why The Bull Case Is Not Entirely Wrong
Looking at KONTR only through balance-sheet fear would also be incomplete. Export sales rose from 593 million TL in 2025Q1 to 1.084 billion TL in 2026Q1. The gross margin improved. If Pomega’s product validations and 3 GWh capacity claim combine with energy-storage demand in Turkey, the income statement may look very different from today’s small operating profit. Plan-S says it has placed 17 satellites in orbit and built a commercial network in IoT/earth observation. Emek Elektrik’s international homologation and export narrative is not empty either.
So the anti-thesis is fair: the balance sheet is bad today, but the options are real. If the paid-in capital increase is completed, cash reduces debt, Pomega moves into shipment and collection, EBITDA rises above 500 million TL per quarter, and no further deterioration comes on the credit-rating side, the stock could make today’s harsh judgment look wrong.
But an investment decision weighs probabilities. The proof in hand today shows the existence of financing pressure as much as the existence of options. JCR Eurasia’s post-balance-sheet downgrade of the long-term national institutional credit rating from BB (tr) to B- (tr), with the outlook turned negative, shows that this pressure is visible from outside too.
Who Can Carry It, Who Cannot?
This stock is not suitable for an investor who treats the sentence “energy storage will grow in Turkey” as a standalone investment thesis. That sentence may be true; still, the shareholder’s return depends on the price at which they enter and how many rights issues they are asked to fund.
KONTR speaks to the investor seeking high option value, willing to accept dilution, and aware that they cannot be comfortable without tracking debt rollover and quarterly EBITDA. For an investor looking for dividends, low balance-sheet risk, clean operating profit, and quiet sleep, this is too noisy a ledger.
My verdict is clear: Distressed. That does not mean the company is worthless. It means the stock today carries, first and foremost, not technology growth but financing tension.
Buying KONTR is not only becoming a partner in a battery factory. It is also accepting that you may have to put money into the charger that keeps that battery alive.